Though the mechanism of S100A9 upregulation in diabetes/obesity and its clinical significance needs to be established, other recent studies [27–29] have demonstrated S100A9 upregulation in diabetes or obesity, further supporting our finding. Here, S100A9 is linked to obesity due to melanocortin 4 receptor deficiency.